Frontlight ResearchEarly access
Trial site
University of Colorado Hospital Anschutz Cancer Pavilion
- 11running trials
- 5closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer3 trials
- Liver and biliary tract cancer3 trials
- Lung cancer3 trials
- Melanoma3 trials
- Childhood cancers2 trials
- Pancreatic cancer2 trials
- Prostate cancer2 trials
- Sarcoma2 trials
- Bladder cancer1 trial
- Brain metastases1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- and 7 more
- Phase
- Phase 36 trials
- Phase 1/24 trials
- Phase 23 trials
- Phase 12 trials
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Dizal Pharmaceuticals2 trials
- Hoffmann-La Roche2 trials
- Biostar Pharma, Inc.1 trial
- Denovo Biopharma LLC1 trial
- Epizyme, Inc.1 trial
- and 9 more
Running trials
Recruiting
Active, not recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Brain metastases1 recruiting
- Childhood cancers1 recruiting
- Melanoma1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026